Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon.

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...

We have launched a new five-year partnership with GlaxoSmithKline (GSK) to enhance the capabilities of African scientists in modern analytical skills.

GSK (GSK) has reportedly delivered the first shipment of its malaria vaccine Mosquirix to Africa, with Cameroon being the first recipient. Read more here.

South Africa expressed confidence that it can get finance ministers and central bank governors from the Group of 20 nations ...

The partners plan to launch a mid-stage Phase IIb clinical study in Kenya, South Africa and India next year, following successful initial tests with the GSK product, Aeras said on Wednesday.

In a bruising Oval Office meeting, the visitors’ plan to keep President Trump from focusing on false accusations of white genocide backfired spectacularly.

A team of infectious disease scientists have been awarded £17.9m to identify new drugs to treat fungal infections.

Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.

When is GlaxoSmithKline (GSK) earnings date? The GlaxoSmithKline (GSK), the NYSE and FTSE listed global pharmaceutical company’s earnings release date is scheduled for the 26th of April 2023. The ...

GSK said in June that widespread foreign exchange shortages in Nigeria were negatively impacting its operations. Soon after, the British multinational pharmaceutical and biotechnology company decided ...

Global healthcare company GlaxoSmithKline (GSK) was chosen for its work in developing simple, cheap, paper-based devices capable of diagnosing infections and saving millions of lives. Here, Graham ...